Perioperative management of patients with valvular heart disease. Clinical guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists” (2nd revision, part 1)

Close metadata

Recommended articles:

Anesthesia for adults in outpatient surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):6-31

Intraoperative monitoring of sedation and analgesia in patients over 70 years old in ENT surgery: a randomized prospective study. Russian Journal of Anesthesiology and Reanimatology. 2024;(4):24-31

Consciousness, sleep, anesthesia. What are we thinking about? Part I. Physiology of consciousness and sleep. Russian Journal of Anesthesiology and Reanimatology. 2024;(5):96-102

Perioperative management of patients with valvular heart disease. Clinical guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists” (2nd revision, part 1). Russian Journal of Anesthesiology and Reanimatology. 2024;(6):6-22

Comparison of prognostic scales of myasthenic crisis after thymectomy in patients with myasthenia gravis. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):63-69

Anatomical features of the structure of the mandibular retromolar triangle as a target point for local anesthesia in dentistry and maxillofacial surgery. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(2):51-58

Efficacy and safety of artificial intelligence-based large language models for decision making support in herniology: evaluation by experts and general surgeons. Pirogov Russian Journal of Surgery. 2024;(8):6-14

Immediate outcomes of simultaneous Cox-Maze procedure in patients with isolated and multivalvular heart defects via right mini-thoracotomy. Pirogov Russian Journal of Surgery. 2024;(12-2):18-24

Current trends in organizing the care for patients with acquired heart valve disease. Russian Cardiology Bulletin. 2024;(4):5-12

Perioperative management of patients with valvular heart disease is a serious problem considering different hemodynamic changes following various valvular lesions. Considering modern data, we present updated information about preoperative assessment of these patients. Recommendations on prevention of thrombosis and infectious endocarditis, as well as intraoperative monitoring are given. We discuss perioperative management of different valvular diseases including preoperative preparation, goals of anesthesia, choice of optimal technique and drugs.

Keywords:

valvular heart disease

perioperative management

anesthesia

guidelines

Authors:

Zabolotskikh I.B.

Kuban State Medical University;
Federal Research Clinical Center of Intensive Care and Rehabilitology;
Krasnodar Regional Clinical Hospital No. 2

SPIN RSCI: 5142-1661
Scopus AuthorID: 6508104506
ResearcherID: O-2705-2014
ORCID: 0000-0002-3623-2546

Bautin A.E.

Almazov National Medical Research Centre

SPIN RSCI: 9415-7300
Scopus AuthorID: 6601992723
ORCID: 0000-0001-5031-7637

Bayalieva A.Zh.

Kazan State Medical University

ORCID: 0000-0001-7577-3284

Grigoryev S.V.

Kuban State Medical University

ORCID: 0000-0002-9753-7351

Zamyatin M.N.

Pirogov National Medical Surgical Center

ORCID: 0000-0002-2072-7798

Kirov M.Yu.

Northern State Medical University

SPIN RSCI: 2025-8162
Scopus AuthorID: 7004841942
ORCID: 0000-0002-4375-3374

Kuzovlev A.N.

Federal Research Clinical Center of Intensive Care and Rehabilitology

SPIN RSCI: 8648-3771
Scopus AuthorID: 35201397900
ResearcherID: F-6462-2017
ORCID: 0000-0002-5930-0118

Lebedinskii K.M.

Federal Research Clinical Center of Intensive Care and Rehabilitology;
Mechnikov North-Western State Medical University

SPIN RSCI: 3590-2308
Scopus AuthorID: 6602775085
ResearcherID: O-8655-2014
ORCID: 0000-0002-5752-4812

Received:

10.04.2024

Accepted:

29.04.2024

List of references:

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. https://doi.org/10.1093/eurheartj/ehab395
Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L, Tutarel O, Van Der Meer P, Wojakowski W, Zacharowski K; ESC Scientific Document Group. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022 Oct 14;43(39):3826-3924. https://doi.org/10.1093/eurheartj/ehac270.
Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-634. https://doi.org/10.1016/s0735-1097(96)00563-3
Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50(13):1205-1213. https://doi.org/10.1016/j.jacc.2007.06.024
Reid CL, Anton-Culver H, Yunis C, Gardin JM. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol. 2007;99(6):830-834. https://doi.org/10.1016/j.amjcard.2006.10.048
Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30(9):962-970. https://doi.org/10.1016/j.cjca.2014.03.022
Chikwe J, Walther A, Pepper J. The Surgical Management of Mitral Valve Disease. Br J Cardiol. 2004;11(1):42-48.
Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, De Bonis M, Tribouilloy C, Evangelista A, Bogachev-Prokophiev A, Apor A, Ince H, Laroche C, Popescu BA, Piérard L, Haude M, Hindricks G, Ruschitzka F, Windecker S, Bax JJ, Maggioni A, Vahanian A; EORP VHD II Investigators. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019;140(14):1156-1169. https://doi.org/10.1161/CIRCULATIONAHA.119.041080.
Tashiro T, Pislaru SV, Blustin JM, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J. 2014;35(35):2372-2381. https://doi.org/10.1093/eurheartj/ehu044
Trekova NA et al. Anesteziya v serdechno-sosudistoj khirurgii. V kn.: Anesteziologiya: natsional’noe rukovodstvo. Bunyatyan AA, Mizikov VM, eds. M.: GEOTAR-Media; 2011:1004. (In Russ.).
Hensley FA Jr, Martin DE, Gravlee GP, eds. A Practical Approach to Cardiac Anesthesia. M.: Meditsinskoe informatsionnoe agentstvo; 2017:1084. (In Russ.).
Herrera A. Valvular Heart Disease. In: Stoelting’s Anesthesia and Co-Existing Disease. 6th ed. Hines RL, Marschall KE, eds. Saunders; 2012.
Herrera A. Valvular Heart Disease. In: Stoelting’s Anesthesia and Co-Existing Disease, 5th ed. Hines RL, Marschall KE, eds. Churchill Livingstone; 2008:2676.
Morgan GE, Mikhail MS. Clinical Anesthesiology. 4th ed. M.: Binom; 2017:1216. (In Russ.).
Wong CJ, Hamlin N.P. The Perioperative Medicine Consult Handbook. New York, NY: Springer; 2013. ISBN 978-1-4614-3219-7. https://doi.org/10.1007/978-1-4614-3220-3
Nussmeier NA et al. Anesthesia for Cardiac Surgical Procedures. In: Miller’s Anesthesia. Translated from English under the general editorship of Lebedinskii KM. SPb: Chelovek; 2015;3:972. (In Russ.).
Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523-e661. https://doi.org/10.1161/CIRCULATIONAHA.108.190748
Bokeria LA. Klinicheskie rekomendatsii po vedeniyu, diagnostike i lecheniyu klapannykh porokov serdtsa. M.: Izd-vo NTsSSKh im. A.N. Bakuleva RAMN; 2009. (In Russ.).
Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302-2308.
Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation. 1972;45(4):878-890. https://doi.org/10.1161/01.cir.45.4.878
Tarasoutchi F, Grinberg M, Spina GS, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol. 2003;41(8):1316-1324. https://doi.org/10.1016/s0735-1097(03)00129-3
Kossmann CE, et al. The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. Boston, MA: Little Brown; 1964:461.
Dubin AA, March HW, Cohn K, Selzer A. Longitudinal hemodynamicand clinical study of mitral stenosis. Circulation. 1971;44:381-389.
Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M,Otto CM. Physical examination in valvular aortic stenosis: correlationwith stenosis severity and prediction of clinical outcome. AmHeart J. 1999;137:298-306.
Parker E, Craige E, Hood WP Jr. The Austin Flint murmur and thea wave of the apexcardiogram in aortic regurgitation. Circulation. 1971;43:349-359.
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL, Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14:611-644.
Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18:254_275
De Hert S, Staender S, Fritsch G, Hinkelbein J, Afshari A, Bettelli G, Bock M, Chew MS, Coburn M, De Robertis E, Drinhaus H, Feldheiser A, Geldner G, Lahner D, Macas A, Neuhaus C, Rauch S, Santos-Ampuero MA, Solca M, Tanha N, Traskaite V, Wagner G, Wappler F. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2018;35(6):407-465. https://doi.org/10.1097/EJA.0000000000000817
Goffinet C, Kersten V, Pouleur AC, et al. Comprehensive assessment of the severity and mechanism of aortic regurgitation using multidetector CT and MR. Eur Radiol. 2010;20(2):326-336. https://doi.org/10.1007/s00330-009-1544-x
Jeger RV, Probst C, Arsenic R, et al. Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J. 2006;151(2):508-513. https://doi.org/10.1016/j.ahj.2005.04.018
Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262-2270. https://doi.org/10.1161/01.cir.95.9.2262
Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26(13):1309-1313. https://doi.org/10.1093/eurheartj/ehi250
2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.).
Ostryj koronarnyj sindrom bez pod”ema segmenta ST elektokardiogrammy. Klinicheskie rekomendatsii. Rossijskoe kardiologicheskoe obshchestvo, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
Ostryj infarkt miokarda s pod”emom segmenta ST elektrokardiogrammy. Klinicheskie rekomendatsii. Rossijskoe kardiologicheskoe obshchestvo, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
Taniguchi T, Morimoto T, Shiomi H, et al. Elective Non-Cardiac Surgery in Patients With Severe Aortic Stenosis — Observations From the CURRENT AS Registry. Circ J. 2020;84(7):1173-1182. https://doi.org/10.1253/circj.CJ-20-0026
Luis SA, Dohaei A, Chandrashekar P, et al. Impact of Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes Following Major Noncardiac Surgery. Mayo Clin Proc. 2020;95(4):727-737. https://doi.org/10.1016/j.mayocp.2019.10.038
Okuno T, Yahagi K, Horiuchi Y, et al. The role of transcatheter aortic valve replacement in the patients with severe aortic stenosis requiring major non-cardiac surgery. Cardiovasc Interv Ther. 2019;34(4):345-351. https://doi.org/10.1007/s12928-019-00575-z
Calleja AM, Dommaraju S, Gaddam R, Cha S, Khandheria BK, Chaliki HP. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol. 2010;105(8):1159-1163. https://doi.org/10.1016/j.amjcard.2009.12.019
Tarantini G, Nai Fovino L, Tellaroli P, Fabris T, Iliceto S. Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery. Am J Cardiol. 2016;117(3): 486-488. https://doi.org/10.1016/j.amjcard.2015.11.020
Sohrabi B, Kazemi B, Mehryar A, Teimouri-Dereshki A, Toufan M, Aslanabadi N. Correlation between Pulmonary Artery Pressure Measured by Echocardiography and Right Heart Catheterization in Patients with Rheumatic Mitral Valve Stenosis (A Prospective Study). Echocardiography. 2016; 33(1):7-13. https://doi.org/10.1111/echo.13000
Bajaj NS, Agarwal S, Rajamanickam A, Parashar A, Poddar KL, Griffin BP, et al. Impact of severe mitral regurgitation on postoperative outcomes after noncardiac surgery. Am J Med 2013;126:529-535.
Authors/Task Force Members:; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4-131. https://doi.org/10.1002/ejhf.2333
Zabolotskikh IB, Bautin AE, Zamyatin MN, Lebedinskii KM, Potievskaya VI, Trembach NV. Perioperative management of patients with chronic heart failure. Russian Journal of Anesthesiology and Reanimatology. 2019;3:5-24. (In Russ.). https://doi.org/10.17116/anaesthesiology20190315
Shiffermiller JF, Monson BJ, Vokoun CW, et al. Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI). J Hosp Med. 2018;13(10):661-667. https://doi.org/10.12788/jhm.3036
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. https://doi.org/10.1093/eurheartj/ehaa612
Bonfanti L, Annovi A, Sanchis-Gomar F, Saccenti C, Meschi T, Ticinesi A, Cervellin G. Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: a real-world 10-year single center experience. Clin Exp Emerg Med. 2019 Mar;6(1):64-69. https://doi.org/10.15441/ceem.17.286
Nadzheludochkovye takhikardii. Klinicheskie rekomendatsii RKO, 2020.(In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
Zabolotskikh IB, Lebedinskii KM, Potievskaya VI, Bautin AE, Eremenko AA, Alekseeva YuM, Doroginin SV. Perioperative management of patients with ventricular tachycardia. Russian Journal of Anesthesiology and Reanimatology. 2020;(6):6-22. (In Russ.). https://doi.org/10.17116/anaesthesiology20200616
Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan L, Kyi HH, Bachuwa G, Hassan M, Stecker EC, Nazer B, Bhatt DL. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2019 Nov;12(11):e007600. https://doi.org/10.1161/CIRCEP.119.007600
Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J, Cronin EM. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020 Jan; 17(1):e206-e219. https://doi.org/10.1016/j.hrthm.2019.04.024.
Sapp JL,Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Ventricular Tachycardia Ablation versus Escalation of coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010 Jan 02;375(9708):31-40. https://doi.org/10.1016/S0140-6736(09)61755-4
Zheludochkovye narusheniya ritma. Zheludochkovye takhikardii i vnezapnaya smert’. Klinicheskie rekomendatsii RKO, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Committee RAS, Investigators. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Eur Heart J. 2014;35(47):3377-3385. https://doi.org/10.1093/eurheartj/ehu305
Avezum A, Lopes RD, Schulte PJ, et al. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Circulation. 2015;132(8):624-632. https://doi.org/10.1161/CIRCULATIONAHA.114.014807
Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, Wallentin L. Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy). Circulation. 2016;134:589-598.
Guimaraes HP, Lopes RD, de Barros ESPGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, de Lemos Soares Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Figueira F, Kojima FCS, Damiani L, Santos RHN, Valeis N, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalhaes CC, Ferreira JFM, Alexander JH, Pavanello R, Cavalcanti AB, Berwanger O, RIVER Trial Investigators. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med. 2020;383:2117-2126.
Shim CY, Seo J, Kim YJ, Lee SH, De Caterina R, Lee S, Hong GR; Explore the Efficacy and Safety of Edoxaban in Patients after Heart Valve Repair or Bioprosthetic Valve Replacement (ENAVLE) study group. Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial. J Thorac Cardiovasc Surg. 2021. https://doi.org/10.1016/j.jtcvs.2021.01.127
Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962. https://doi.org/10.1016/S0140-6736(13)62343-0
Zabolotskikh IB, Kirov MYu, Afonchikov VS, Bulanov AYu, Grigoryev EV, Grigoryev SV, Gritsan AI, Zamyatin MN, Kurapeev IS, Lebedinskii KM, Lomivorotov VV, Lubnin AYu, Ovechkin AM, Potievskaya VI, Roitman EV, Sinkov SV, Subbotin VV, Shadrin RV, Shulutko EM. Perioperative management of patients receiving long-term antithrombotic therapy. Clinical practice recommendations of the national “Federation of Anesthesiologists and Reanimatologists”. Annals of Critical Care. 2021;(3):7-26. (In Russ.). https://doi.org/10.21320/1818-474X-2021-3-7-26
Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635-641.
Mok CK, Boey J, Wang R, et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation. 1985;72(5):1059-1063. https://doi.org/10.1161/01.cir.72.5.1059
Christersson C, James SK, Lindhagen L, Ahlsson A, Friberg O, Jeppsson A, Stahle E. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement. Heart 2020;106:838-844.
Pernod G, Godiér A, Gozalo C, Tremey B, Sié P; French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res. 2010;126(3):e167-e174. https://doi.org/10.1016/j.thromres.2010.06.017
Caldeira D, David C, Santos AT, Costa J, Pinto FJ, Ferreira JJ. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis. J Thromb Haemost. 2014;12(5):650-659. https://doi.org/10.1111/jth.12544
Spyropoulos AC, Turpie AG, Dunn AS, Kaatz S, Douketis J, Jacobson A, Petersen H, REGIMEN Investigators. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol. 2008;102:883-889.
Pozhidaeva AM, Irtyuga OB, Yakubov AV, Badalyan N, Zhuravleva MS, Sefieva GG, Shadrina UM, Li OA, Pervunina TM, Zazerskaya IE, Vavilova TV, Bautin AE. Strategy of re-administering anticoagulants after delivery in patients with mechanical prosthetic heart valves. Tromboz, gemostaz i reologiya. 2023;3:28-37. (In Russ.). https://doi.org/10.25555/THR.2023.3.1066
The 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3036-3037. https://doi.org/10.1093/eurheartj/ehv488
Roizen MF, Fleisher LA. In: Miller RD, ed. Anesthetic implication of concurred diseases in Miller’s anesthesia. 6th ed. Elsevier; 2005.

Close metadata